BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3530350)

  • 1. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.
    Lehn P; Sigaux F; Grausz D; Loiseau P; Castaigne S; Degos L; Flandrin G; Dautry F
    Blood; 1986 Oct; 68(4):967-70. PubMed ID: 3530350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
    Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
    Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-IFN treatment does not induce Ki-ras expression in hairy-cell leukemia patients.
    Giron ML; Mercier G; Sigaux F; Castaigne S; Flandrin G; Degos L; Emanoïl-Ravier R
    Blut; 1989 Feb; 58(2):83-4. PubMed ID: 2645955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment.
    Marolleau JP; Henni T; Gaulard P; Le Couedic JP; Gourdin MF; Divine M; Katz A; Tulliez M; Goossens M; Reyes F
    Blood; 1988 Aug; 72(2):655-60. PubMed ID: 2840988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
    Marshall AH; Alper D; Hiscott J
    J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.
    Sainati L; Matutes E; Mulligan S; de Oliveira MP; Rani S; Lampert IA; Catovsky D
    Blood; 1990 Jul; 76(1):157-62. PubMed ID: 2364167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cellular oncogenes in primary cells from human acute leukemias.
    Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha.
    Giardina SL; Young HA; Faltynek CR; Jaffe ES; Clark JW; Steis RG; Urba WJ; Mathieson BJ; Gralnick H; Lawrence J
    Blood; 1988 Nov; 72(5):1708-16. PubMed ID: 2846090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
    Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapy.
    Fridrik MA; Wahl G; Herbinger W; Schützenberger W; Gastl G; Huber C; Krönke M; Höpfel I
    Blut; 1989 May; 58(5):261-4. PubMed ID: 2720174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-myc RNA and its proteins in Daudi cells by interferon-beta.
    Jonak GJ; Friedland BK; Anton ED; Knight E
    J Interferon Res; 1987 Feb; 7(1):41-52. PubMed ID: 3295065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages.
    Myers MJ; Ghildyal N; Schook LB
    Immunology; 1995 Jun; 85(2):318-24. PubMed ID: 7642223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
    Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP
    Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
    Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
    Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
    Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.